首页|瑞芬太尼联合舒芬太尼对内镜黏膜下剥离术患者的影响

瑞芬太尼联合舒芬太尼对内镜黏膜下剥离术患者的影响

扫码查看
目的:探讨瑞芬太尼联合舒芬太尼对内镜黏膜下剥离术患者的影响。方法:选取 2022 年 6 月—2023 年 6 月蚌埠医科大学第一附属医院收治的 80 例内镜黏膜下剥离术患者。随机将其分为对照组和观察组,各 40 例。两组均给予内镜黏膜下剥离术,对照组给予瑞芬太尼麻醉诱导,观察组给予瑞芬太尼联合舒芬太尼麻醉诱导。比较两组麻醉开始前、麻醉诱导完成后、手术开始时、手术结束时心率(HR)、平均动脉压(MAP),手术开始时及手术结束时应激指标,镇静效果及不良反应。结果:麻醉诱导完成后、手术开始时、手术结束时,两组HR、MAP水平均降低,观察组HR、MAP水平均高于对照组,差异有统计学意义(P<0。05)。手术结束时,两组肾上腺素(E)、去甲肾上腺素(NE)水平均升高,观察组E、NE水平均低于对照组,差异有统计学意义(P<0。05)。观察组拔管时间及睁眼时间均短于对照组,躁动评分低于对照组,差异有统计学意义(P<0。05)。两组术后不良反应发生率比较,差异无统计学意义(P>0。05)。结论:瑞芬太尼联合舒芬太尼在内镜黏膜下剥离术中应用良好,可有效稳定患者术中血流动力学,促进患者尽快苏醒,减轻患者术后应激及清醒后躁动。
Effect of Remifentanil Combined with Sufentanil on Patients Undergoing Endoscopic Submucosal Dissection
Objective:To investigate the effect of Remifentanil combined with Sufentanil on patients undergoing endoscopic submucosal dissection.Method:A total of 80 patients with endoscopic submucosal dissection admitted to the First Affiliated Hospital of Bengbu Medical University from June 2022 to June 2023 were selected.They were randomly divided into control group and observation group,40 cases in each group.Both groups were given endoscopic submucosal dissection,the control group was given Remifentanil anesthesia induction,and the observation group was given Remifentanil combined with Sufentanil anesthesia induction.Heart rate(HR),mean arterial pressure(MAP)before anesthesia begins,after anesthesia induction is completed,at the beginning of operation,and at the end of operation,stress index at the beginning and end of operation,sedation effect and adverse reactions were compared between the two groups.Result:After anesthesia induction is completed,at the beginning of operation and at the end of operation,HR and MAP levels in both groups were decreased,and HR and MAP levels in the observation group were higher than those in the control group,the differences were statistically significant(P<0.05).At the end of the operation,the levels of epinephrine(E)and norepinephrine(NE)in both groups were increased,and the levels of E and NE in the observation group were lower than those in the control group,the differences were statistically significant(P<0.05).The extubation time and eye opening time of the observation group were shorter than that of the control group,and the agitation score was lower than that of the control group,the differences were statistically significant(P<0.05).There was no significant difference in the adverse reactions of postoperative complications between the two groups(P>0.05).Conclusion:Remifentanil combined with Sufentanil is well applied in endoscopic submucosal dissection,which can effectively stabilize intraoperative hemodynamics of patients,promote patients to wake up as soon as possible,and alleviate patients'post-operative stress and agitation after awakening.

RemifentanilSufentanilEndoscopic submucosal dissectionHemodynamics

于汝、梁启胜

展开 >

蚌埠医科大学第一附属医院 安徽 蚌埠 233000

瑞芬太尼 舒芬太尼 内镜黏膜下剥离术 血流动力学

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(19)